Norton Rose is one of Canada's leading law firms and one of the largest, with five offices across the country and close to 700 lawyers. Its IP group has more than 70 professionals and a strong reputation in patent litigation, particularly in the pharmaceutical and life sciences sectors. Clients include Pfizer, GlaxoSmithKline and Merck.
The firm also represents some of the most active patent filers in the world, such as Johnson & Johnson, Research in Motion and Bombardier. It also manages the trade mark portfolios of Henkel, Akzo Nobel, Dial, Delmonte, Head and Heinz.
The merger with Macleod Dixon in January 2012 resulted in the firm's expansion as well as an IP presence in Calgary. Norton Rose and Fulbright & Jaworski are also set to merge in June 2013. The new entity, Norton Rose Fulbright, will have 3,800 lawyers and 55 offices worldwide.
The firm lost one of its partners last year with the retirement of Malcolm McLeod. He continues to work for the firm as a consultant, however, on knowledge management projects.
Adrienne Blanchard, formerly of Gowling Lafleur Henderson, joined the firm as partner in September 2012. The firm acquired another new partner in November of the same year, with the addition of Anthony de Fazekas, who joined from Miller Thomson.
Peers recognise the firm's leading position in patents. They also praise Patrick Kierans, identifying him as one of the top litigators in Canada.